Assessment of the quality and content of national and international guidelines on hypertensive disorders of pregnancy using the AGREE II instrument

por Bazzano, Alessandra N, Green, Erik, Madison, Anita, Barton, Andrew, Gillispie, Veronica, Bazzano, Lydia A L
Publicado 2016

Efficacy and safety of elagolix with add-back therapy in women with uterine fibroids and coexisting adenomyosis

por Muneyyirci-Delale, Ozgul, Archer, David F., Owens, Charlotte D., Barnhart, Kurt T., Bradley, Linda D., Feinberg, Eve, Gillispie, Veronica, Hurtado, Sandra, Kim, Jin Hee, Wang, Alice, Wang, Hui, Stewart, Elizabeth A.
Publicado 2021

Predictors of response for elagolix with add-back therapy in women with heavy menstrual bleeding associated with uterine fibroids

por Al-Hendy, Ayman, Bradley, Linda, Owens, Charlotte D., Wang, Hui, Barnhart, Kurt T., Feinberg, Eve, Schlaff, William D., Puscheck, Elizabeth E., Wang, Alice, Gillispie, Veronica, Hurtado, Sandra, Muneyyirci-Delale, Ozgul, Archer, David F., Carr, Bruce R., Simon, James A., Stewart, Elizabeth A.
Publicado 2021

Elagolix Treatment for Up to 12 Months in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas

por Simon, James A., Al-Hendy, Ayman, Archer, David F., Barnhart, Kurt T., Bradley, Linda D., Carr, Bruce R., Dayspring, Thomas, Feinberg, Eve C., Gillispie, Veronica, Hurtado, Sandra, Kim, JinHee, Liu, Ran, Owens, Charlotte D., Muneyyirci-Delale, Ozgul, Wang, Alice, Watts, Nelson B., Schlaff, William D.
Publicado 2020